Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response

Mol Psychiatry. 2005 Apr;10(4):332-3. doi: 10.1038/sj.mp.4001634.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Anxiety / chemically induced*
  • Depression / chemically induced*
  • Drug Carriers / adverse effects
  • Drug Carriers / therapeutic use
  • Drug Therapy, Combination
  • Fatigue / chemically induced*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / psychology
  • Hepatitis C, Chronic / virology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Male
  • Middle Aged
  • Polyethylene Glycols
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Severity of Illness Index
  • Substance-Related Disorders / psychology
  • Time Factors
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Drug Carriers
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b